Thereupon, clarifying the GOF activity of each mut-p53 and its underlying impacts on lung cancer progression and prognosis in the context of a specific mutation site, may contribute to achieving a more precise monitoring and management of lung cancer. This evidence concerns the gene TP53 and lung cancer.